Dr. William J. Crumb Jr., Ph.D., President and CEO of Nova Research Laboratories, LLC, has collaborated with Dr. Andrew G. Edwards, Ph.D., Chief Research Scientist of Simula Research Laboratory in ...
Medical Device Network on MSN
Laza Medical secures $160m to advance robotic imaging system
The technology remains under active development and has not received regulatory clearance or approval.
<?xml encoding="utf-8" ?> Lexicon Pharmaceuticals LXRX reported third-quarter financial results on Thursday. The transcript ...
Management call today at 3.30 pm CEST Newron received the anticipated FDA written communication on clinical hold at U.S. study centers and is reviewing feedback and preparing its response ENIGMA-TRS 1 ...
Newron continues to advance the Phase 3 ENIGMA-TRS development program. ENIGMA-TRS 1 enrollment is expected to be completed by mid-October, with topline 12-week data expected in Q1 2027. ENIGMA-TRS 2 ...
JCI InsightCystatin C is a laboratory test item commonly used in clinical practice to evaluate kidney function. However, cystatin C secreted by immune cells surrounding the heart may have a role in ...
Even if a patient's medical record for heart failure states 'shortness of breath present' or 'lower limb edema present,' that ...
In symptomatic patients with preserved ejection fraction, beta blockers, nondihydropyridine calcium channel blockers (verapamil and diltiazem), and disopyramide have been the mainstay of first-line ...
St. Francois County’s 911 board unanimously approved a $6.2 million 2027 budget, expanded sick-leave payouts and authorized ...
CardioComm Solutions, Inc. announced a collaboration with CancerCare Manitoba ("CCMB") on a pilot study evaluating remote electrocardiogram ("ECG") monitoring for potential QT/QTc interval ...
Detailed price information for Cardiocomm Solutions Inc (EKG-X) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results